טוען...
Pre-Transplant Therapy with Azacitidine Versus Induction Chemotherapy and Post-Transplant Outcome in Patients with MDS
While allogeneic hematopoietic cell transplantation (HCT) has proven curative potential for myelodysplastic syndrome (MDS), relapse after HCT remains a problem. Pre-transplant cytoreduction with induction chemotherapy (IC) has been utilized to reduce relapse rates, but is associated with significant...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3376402/ https://ncbi.nlm.nih.gov/pubmed/22252125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.01.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|